When a Chinese VC Redemption Right Follows the Founder Home

Your company misses an IPO deadline. The investor sends a redemption notice. The amount due is the original investment plus an annual return. The company does not have the cash, which is unsurprising because companies that miss IPO deadlines rarely keep a spare redemption fund beside the office snacks.

Then counsel points to the founder’s signature.

This is the part that gets lost when Chinese and US term sheets use the same phrase. In a conventional Delaware venture financing, preferred-stock redemption is an obligation of the corporation, constrained by capital and solvency law. Delaware Code section 160 restricts redemptions that impair capital, and the Delaware Supreme Court upheld a company’s refusal to satisfy a full redemption demand when the investor failed to prove that sufficient funds were legally available.¹¹¹² A later Court of Chancery opinion stated that even a ripened redemption right does not automatically turn preferred stock into debt or create an unfettered right to payment.¹³

In a Chinese financing, the documents may make the founder or controlling shareholder a direct repurchase obligor. They may instead make the founder a guarantor, sometimes on a joint-and-several basis. The company can fail while that separate promise survives.

The distinction is now expensive. Reuters reported in November 2024 that Lifeng Partners estimated about 14,000 Chinese startups were exposed to redemption demands. Redemption exits had nearly tripled to 641 in 2023 and rose another 68% year over year in the first nine months of 2024, according to Zero2IPO data cited by Reuters.¹ Han Kun estimated that redemption rights appeared in more than 90% of onshore Chinese VC and private-equity transactions and more than three-quarters of offshore deals.²

This article is a map, not an opinion on any particular contract. Chinese and US entities, offshore holding companies, arbitration clauses, governing law, and the precise signatures can change the result. Your lawyer needs the complete document set. You need to know what to ask them.

Start by ignoring the heading. “Redemption right” may describe at least three arrangements.

First, the company may promise to repurchase the investor’s equity after a missed IPO, missed performance target, or another event. Chinese courts have treated the validity of that agreement separately from whether the company can perform it without violating capital-maintenance rules. The Supreme People’s Court’s 2019 Ninth Civil and Commercial Conference Minutes said courts should generally respect a valuation adjustment agreement between an investor and the target company, while examining whether actual performance complies with mandatory rules governing capital withdrawal, share repurchases, and profit distributions.³ A valid sentence does not manufacture distributable cash.

Second, the founder, controlling shareholder, or actual controller may directly promise to buy the shares. This is the dangerous version for a founder. The claim runs against the person who made the promise. It does not need the company to have legally distributable funds in the same way a company-funded repurchase does.

Third, the company may owe the repurchase amount while a founder guarantees payment. Under articles 686 to 688 of China’s Civil Code, an ordinary guarantee and a joint-and-several guarantee have different collection mechanics. Where the contract expressly creates joint-and-several liability, the creditor may seek performance from the debtor or the guarantor after the debt comes due.⁴

The investor is a shareholder while upside is available and a creditor when the downside arrives. That is a remarkably full-service interpretation of risk capital.

Do not let the cap table answer a contract question. The cap table shows who owns the shares. It does not show which natural person promised to buy them later. This is the same reason dilution modelling cannot reveal every financing risk: ownership arithmetic and personal recourse live in different documents.

Redemption language was easier to dismiss during the boom. An IPO deadline five or six years away looks less like a debt maturity and more like an item for Future Founder, who is expected to have better hair and a Nasdaq ticker.

The deadline becomes real even when the exit environment changes. In January 2024, the China Securities Regulatory Commission said it had tightened the pace of mainland IPO issuance from late August 2023. It approved 213 IPOs and launched 193 between January and August 2023, then approved 32 and launched 44 from September through December.⁵ A contractual IPO clock does not pause because the regulator narrows the gate.

Public financing documents show how the maturity moves. One SEC-filed agreement gave Series D investors a redemption right if the company failed to complete a qualifying IPO or trade sale by 31 December 2025. The deadline could move to 31 December 2026 if an application had been submitted and specified legal, regulatory, market, or policy changes caused the board to postpone. The price included the original issue price plus an 8% annual compounded return.⁶ That is one disclosed deal, rather than proof of a universal template. It demonstrates why financings signed in 2019 through 2021 can produce deadlines during 2025 through 2027 when their clocks run for five to seven years.

The arithmetic also changes with time. A RMB 50 million obligation accruing at 8% compounded annually becomes about RMB 79.3 million after six years. The company received RMB 50 million. The person named as repurchase obligor may owe the larger number after the planned exit fails. Meanwhile, liquidation preferences can still govern what that investor receives in a sale. One financing can offer several doors out; common shareholders are rarely given the same architectural generosity.

This is why the current reckoning can continue through 2027 without a new wave of bad clauses. Old clocks are sufficient. Each missed milestone converts a provision everyone treated as leverage into a notice somebody has to answer.

The ugliest version of this story skips from “missed IPO” to “founder cannot board a train.” The actual sequence matters.

The trigger must occur under the contract. The investor must exercise the right in the required manner and within any applicable period. A dispute may go to arbitration or court, depending on the forum clause. The investor then needs an enforceable award, judgment, or settlement. If the obligor does not perform, the creditor can seek judicial enforcement against assets that legally answer for the debt.

Only after that do China’s enforcement restrictions enter the picture. The Supreme People’s Court’s rules allow courts to restrict high consumption by an individual judgment debtor who fails to perform within the enforcement notice period. The listed restrictions include flights, all seats on G-series high-speed trains, first-class or higher seats on other high-speed trains, and high spending at starred hotels.⁷ The hotel minibar has finally found a matter of public policy large enough to justify its pricing.

The dishonest judgment-debtor list is related, though it is not a synonym for any unpaid judgment. Under the SPC’s rules, the debtor must have failed to perform an effective legal instrument and meet a specified ground. Those grounds include having the ability but refusing to perform, evading enforcement, violating the property-reporting system, violating a consumption restriction, or refusing an enforcement settlement without justification.⁸ Genuine inability to pay does not, by itself, satisfy every route onto the list.

That legal distinction should not comfort a founder who signed an uncapped obligation. A creditor can still pursue available personal assets, and enforcement proceedings can dominate the founder’s finances and working life. The accurate warning is severe enough. It does not need the fiction that every unpaid repurchase notice instantly cancels a boarding pass.

For years, Chinese courts disagreed about the legal character of an investor’s repurchase election and how long the investor could wait after a trigger. An indefinite option creates a peculiar company: management operates it while an investor keeps a dormant right to reprice the past.

On 30 September 2025, the Supreme People’s Court published a draft interpretation of the Company Law for public comment. Article 37 would confirm the general validity of valuation adjustment agreements involving a company, shareholder, or actual controller, subject to the draft’s other rules. It would refuse performance of a company repurchase where the company had not lawfully completed a capital reduction or profit distribution. It would also distinguish company security from security supplied by a third party.⁹

Draft article 38 addresses the investor’s election against a shareholder. If the agreement supplies an exercise period, the investor must use it. If the shareholder demands a decision, the investor must choose within a reasonable period. A later repurchase claim would fail unless the shareholder agrees.⁹ The provision tries to stop a contingent exit right from floating over the company forever, which is a surprisingly radical demand to make of a deadline.

The draft did not itself write a universal six-month limit. A Supreme People’s Court justice said publicly in December 2025 that six months should generally be the reasonable period where a PE or VC agreement provides no exercise period, according to Chambers’ 2026 China venture-capital guide.¹⁰ That statement offers direction. It is not the same thing as enacted text.

As of 24 August 2026, the September 2025 proposal remains a draft; the Supreme People’s Court’s published list of judicial interpretations contains no final version.¹⁴ A founder should use its direction in negotiations without assuming it has already erased a live claim. Put an express exercise period in the contract, put a date in the calendar, and have Chinese counsel assess any existing trigger under the law and forum that actually govern it.

The review should begin with the obligor, not the trigger. Search the complete document set for the founder’s name, “actual controller,” “controlling shareholder,” “repurchase obligor,” “guarantor,” “joint and several,” “compensation,” and equivalent Chinese terms. Check the investment agreement, shareholders’ agreement, side letters, guarantees, accession documents, and any spouse-related consent or property document.

Then build a one-page exposure schedule:

• Identify whether liability is caused by fraud or serious founder misconduct, or by an objective company outcome such as missing an IPO, revenue target, or valuation.
• Identify which investment amount is covered and whether one investor’s demand can trigger other rounds.
• Calculate whether the premium is simple or compounded and whether it continues during a dispute and after judgment.
• State whether the founder’s exposure is unlimited, capped at a number, or limited to the value or proceeds of specified shares.
• Classify the founder as a direct purchaser, an ordinary guarantor, or a joint-and-several guarantor.
• Record the required notice, every recipient, and the date on which the right expires.
• Require the investor to tender the shares free of claims and specify what happens to voting, information, preference, and dividend rights while payment is outstanding.
• Add release conditions after an agreed financing, submitted IPO application, clean compliance period, investor secondary sale, or departure without cause.
• Confirm which law, court, or arbitral institution controls and where an award could be enforced.

Run the return formula through the latest possible exercise date. Add every round that can demand redemption. A clause reviewed one paragraph at a time can look manageable while the aggregate exposure exceeds the founder’s net worth several times over. Personal solvency is one of those details fundraising decks traditionally leave to the appendix, somewhere after the total addressable market.

For an existing clause, record every trigger and notice now. Preserve board materials, regulatory correspondence, investor waivers, extension discussions, and proof of when each party learned that a milestone would be missed. Do not rely on the investor relationship to supply an extension. Relationships become evidence with unusual speed once a fund needs distributions.

A founder should be personally liable for their own fraud, asset diversion, deliberate concealment, and other defined misconduct. That is accountability for conduct.

An uncapped promise to repay an equity investment because the company missed an IPO or revenue target is different. It moves ordinary venture risk from the fund to one individual while leaving the fund’s upside intact. The investor receives preferred economics if the company succeeds and principal plus a return claim if an external exit deadline fails. Calling that “alignment” asks one word to carry the entire fund model up several flights of stairs.

I would refuse uncapped founder recourse for an objective business outcome. If the investor will not remove personal liability, I would narrow it to exhaustively defined founder misconduct, cap it, make liability several rather than joint where several founders sign, remove compounding, add a short exercise window and cure period, and require the investor to tender every attached equity right upon payment. I would also make the liability fall away when the company reaches an agreed financing, governance, or filing milestone.

This is a price term. A fund demanding equity upside plus founder recourse is offering a different product from conventional risk capital. Compare its valuation with a lower valuation from an investor that accepts company-level downside. How founders exit with nothing explains what preferred economics can already do inside the company. Personal redemption liability adds a claim outside it.

Some founders will still accept the term because the alternative is no financing. That can be a rational choice. It should appear in the approval materials as a maximum personal exposure, not as two lines beneath “standard investor protections.” Have the board record the company benefit and have each affected founder receive independent advice. Company counsel represents the company. A signature that reaches your personal assets deserves counsel whose client is you.

Ask the lead investor to mark every provision that can require a natural person to transfer cash or property. Ask for the most founder-favourable version the fund has signed in the past year. Model the amount due on every trigger date. Negotiate the recourse package while the investor still needs your signature.

“Standard” is a word that grows more reassuring with the seniority of the person saying it and more expensive with the liability of the person signing it.

Then give your lawyer a narrow written instruction: identify every direct or contingent personal obligation; state the trigger, cap, duration, defences, release, dispute forum, and enforcement route for each; and explain what survives company insolvency, founder departure, a failed IPO, and a sale below the preference stack.

The three words “redemption right” do not tell you who owes the money. The signature page does. Read that page before the company’s missed milestone turns it into a personal balance sheet.